Uncategorized
FDA approves Lucentis for all forms of diabetic retinopathy
The FDA has approved Lucentis for monthly treatment of all forms of diabetic retinopathy, according to a press release from Genentech/Roche.The 0.3 mg injection of ranibizumab is the first FDA drug approved to treat diabetic retinopathy “with or without diabetic macular edema,” according to the release.